Clinical trial

Gestational Response, Outcomes, and Weight After GLP-1 Use

Recruiting now · Not applicable · 1 countries · Registry ID NCT07743567

Recruiting nowNot applicableObservational

What this study is about

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to: * Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure. * Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure. Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences. Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 45 Years
SexFemale
Healthy volunteersAccepted
ConditionPregnant Individuals, Obesity & Overweight, Gestational Weight Gain

Full registry criteria

Inclusion Criteria: * Adult women * Less than or equal to 20 weeks gestation at first visit * English speaking Exclusion Criteria: * \<18 years at time of initial visit * Type 2 diabetes * History of bariatric surgery * Multiple gestation * Cannot consent for themselves * Cannot read and speak English * Incarcerated

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Gestational weight gainFrom the start of pregnancy to delivery.

Total gestational weight gain, calculated from clinical weight measurements recorded in the electronic medical record and compared between participants with preconception GLP-1RA exposure and those without exposure.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

University of Kansas Medical Center🇺🇸 Kansas City, Kansas, United States
Molly FainContact
Johanna Finkle, MDPrincipal Investigator